Anja Apel

Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature.

Corrigendum: GH responsiveness is not correlated to IGF1 P2 promoter methylation in children with Turner syndrome, GHD and SGA short stature.

Journal: Frontiers in endocrinology

Published: August 16, 2022

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature.

GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature.

Journal: Frontiers in endocrinology

Published: March 16, 2022

A neuronal blood marker is associated with mortality in old age.

A neuronal blood marker is associated with mortality in old age.

Journal: Nature aging

Published: October 07, 2020

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Journal: Frontiers in neurology

Published: September 08, 2018

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Journal: Nature medicine

Published: July 11, 2018

SNPs in Aβ clearance proteins: Lower CSF Aβ1-42 levels and earlier onset of dementia in PD.

SNPs in Aβ clearance proteins: Lower CSF Aβ1-42 levels and earlier onset of dementia in PD.

Journal: Neurology

Published: November 23, 2016

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.

Journal: European journal of neurology

Published: September 13, 2016

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Journal: Neuron

Published: August 02, 2016

Inflammatory profile in LRRK2-associated prodromal and clinical PD.

Inflammatory profile in LRRK2-associated prodromal and clinical PD.

Journal: Journal of neuroinflammation

Published: January 31, 2016

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.

Journal: Neuron

Published: January 15, 2016

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.

Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 22, 2015

Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.

Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.

Journal: PloS one

Published: October 29, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026